Navigation Links
GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
Date:3/30/2009

RESEARCH TRIANGLE PARK, N.C., March 31 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE: GSK) has entered into a co-promotion agreement with Shire plc (LSE: SHP, Nasdaq: SHPGY) for Vyvanse(R), to help improve the recognition and treatment of adult Attention Deficit Hyperactivity Disorder (ADHD). This 3-year agreement covers the United States only and will add an important product to the GSK Neurosciences portfolio.

"GSK has been active in discovering and developing medicines to treat psychiatric disorders for decades, and neuroscience is one of the company's key therapeutic categories," said Deirdre Connelly, President, GlaxoSmithKline North American Pharmaceuticals. "Our professional

sales representatives are well positioned to provide physicians with information on the treatment of adult ADHD with Vyvanse and we look forward to helping meet the needs of adult patients with ADHD."

"Shire believes GSK is our ideal partner to promote Vyvanse because of its strength and leadership in CNS treatments," said Michael Cola, President of Shire's Specialty Pharmaceuticals business. "By collaborating with GSK, we are better positioned to reach psychiatrists and primary care physicians with treatment information about adult ADHD."

The GSK sales force is expected to begin promoting Vyvanse to physicians in May 2009.

Vyvanse is a prodrug of dextroamphetamine, a stimulant, which is therapeutically inactive until metabolized in the body. Vyvanse is currently available in six dosage strengths o
'/>"/>

SOURCE GlaxoSmithKline plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... 2015 , ... Doctor Kayode Sotonwa can be counted on time ... on internal medicine keeps patients happy and healthy, something that is important to everyone. ... season, but even more so in the fall, when holiday eating and seasonal illnesses ...
(Date:9/3/2015)... ... 2015 , ... Fashion designer Kim (29 years old, Honolulu, HI) designed her ... the hit ABC series “Extreme Weight Loss” Season 5 . Standing just 5’1” ... herself with the motivation to transform when she designed a drop-dead-gorgeous dress and vowed ...
(Date:9/2/2015)... ... September 03, 2015 , ... Leah ... among the most influential leaders in healthcare, will offer the keynote address at ... place October 15-16, 2015, in Palm Harbor, Florida, at the Innisbrook Resort and ...
(Date:9/2/2015)... ... 2015 , ... Sara Bleich, Ph.D., associate professor of health ... an internationally recognized scholar on obesity prevention and control, has been selected for ... and 1996 graduate of Garrison Forest School, an all-girls’ independent school in Owings ...
(Date:9/2/2015)... , ... September 02, 2015 , ... The CRISPR-Cas9 ... using a complex of the Cas9 nuclease with either a chimeric single guide RNA ... The ability of any given guide RNA (sgRNA or crRNA) to create a break ...
Breaking Medicine News(10 mins):Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4
... A commentary in the December issue of The Lancet ... on the transmission of a common pathogen the influenza ... to protect health care workers. Infectious diseases specialist Leonard Mermel, ... looks at the ongoing debate in light of the H1N1 ...
... the University of Southern California Center for Robotics ... evaluate robots as exercise coaches for adults of all ... The effort, entitled "Robot Motivator: Towards Adaptive Health Games ... virtual social characters on people,s motivation to exercise. ...
... Woman and Her Provider is the Best Choice for Screening ... mammography emphasizes that the best decision on screening is made ... woman,s individual medical history, risks, and concern level about breast ... as a guide and not as something fixed in concrete," ...
... , MIAMI, Nov. 19 Astor ... a Healthcare Portfolio Analyst with Citadel Investment Group. ... the investment bank continues to experience robust activity in ... Seth Zalkin, Managing Partner of Astor Group. , As ...
... a bill has been introduced in the Senate, USAction today ... to allow debate to begin so that the country can ... for all. , "Majority Leader Reid has demonstrated principled leadership ... Charney. "Now it,s time for every member of the Democratic ...
... , CARDIFF, Calif., Nov. 19 Jedi Mind, ... ), a thought-controlled and mind-controlled gaming and medical applications Company, ... the Company, new products coming out and the airing of ... Headline News. , The Company is working on multiple ...
Cached Medicine News:Health News:Preventing H1N1 spread to health care workers: Dilemma, debate and confusion 2Health News:Breaking Through the Mammography Controversy 2Health News:Astor Group Expands Healthcare Practice With Hiring of Chris Dimitropoulos 2Health News:60 Votes: Democratic Caucus Must Move Forward With Promise of Quality, Affordable Health Care for All With a Public Insurance Option 2Health News:Thought-Controlled Game; Jedi Mind, Inc. Provides Update on Progress 2
(Date:9/2/2015)... About Duchenne muscular dystrophy Duchenne ... affects the male population. It is characterized by ... caused due to mutations in the dystrophin gene, ... dystrophin (a protein essential for maintaining healthy muscle ... muscle function, causes loss of ambulation, harms the ...
(Date:9/2/2015)... -- About Chronic Lymphocytic Leukemia Chronic ... production of lymphocytes. It has been observed that the ... to other parts of the body. This leukemia is ... buildup of the cancerous cells. During the course of ... and lymph nodes. The course of the disease is ...
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 Research and ... "Pharmaceutical Regulatory Affairs in China (Basel, Switzerland - November ... This seminar will provide a detailed overview of the key ... , Hong Kong , Macau ... cover: - All important aspects of gaining ...
Breaking Medicine Technology:Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2
... FRANCISCO, Oct. 14 Medizone International, Inc. ... round of AsepticSure(TM) trials have begun at Innovation Park, ... the first and second round of laboratory testing, this ... protocols necessary in order to obtain maximum bactericidal action ...
... Oct. 14 Cardiva Medical, Inc. announces today that its ... position of Chief Executive Officer at Innovative Energy, Inc., an ... of Cardiva Medical stated, "I would like to thank Glenn ... During his tenure as President, we have transformed Cardiva ...
Cached Medicine Technology:Medizone International Announces Third Round of AsepticSure 2Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc. 2Cardiva Medical, Inc. Announces the Departure of its President and his Appointment as CEO of Innovative Energy, Inc. 3
... their eyes for granted. Like the ... need proper nutrition and care to ... as you age. In fact, research ... maintaining and preserving eye health for ...
Expert QC data management solution...
The Vision Premier software features advanced,capabilities, including automatic categorization,of beats, tachogram review and full-disclosure,viewing, providing the tools needed for even,the ...
... The OmniPod: a small, lightweight self-adhesive insulin ... directly on your body for up to three ... personalized doses of insulin into your body through ... on instructions that you program into its wireless ...
Medicine Products: